InvestSMART

Atomo Diagnostics Limited (ASX:AT1)

ALERT: Price-sensitive ASX Announcement for AT1
Current share price for AT1 : $0.018 -0.004 (-18.18%)+
Announcement
Release
15 May 2026 11:06AM
Price at Release
$0.022
Full Release
download
Summary
Atomo Diagnostics Limited announced the results of its Share Purchase Plan (SPP) which closed on 8 May 2026, raising $44,500 from 1,348,480 shares before costs. Shareholders from Australia and New Zealand as of 27 March 2026 could subscribe for shares at $0.033 each, with the company accepting all valid applications in full and offering free attaching options exercisable at $0.045, expiring in 2.5 years. The shares will rank equally with existing shares, and the company has a shortfall placement option of $955,500. John Kelly, Managing Director & CEO, thanked the shareholders for their support, and the announcement was authorized by the Board.
Key Points
  • Atomo Diagnostics Limited announced the results of its Share Purchase Plan (SPP).
  • The SPP closed on 8 May 2026, raising $44,500 before costs from 1,348,480 shares.
  • Eligible shareholders were from Australia and New Zealand as of 27 March 2026.
  • Shareholders could subscribe for up to $30,000 of new ordinary shares at $0.033 per share.
  • The company accepted all valid applications in full according to the Prospectus dated 16 April 2026.
  • Each share comes with free attaching options exercisable at $0.045, expiring in 2.5 years.
  • SPP shares will rank equally with existing shares.
  • The company has a shortfall placement option amounting to $955,500.
  • John Kelly, Managing Director & CEO, expressed gratitude to shareholders for their participation.
  • The announcement was authorized by the Board.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.